Eli Lilly (LLY) CFO says the orforglipron pill could potentially come to the US market as early as Q2 following expected April approval, via Conference
Importance
Level 1
#ELI LILLY & CO#LLY.US#EQUITIES#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#ELI LILLY AND CO#LLY#US EQUITIES